Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
65.42 USD | -0.24% | -0.83% | +4.16% |
05-08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.16% | 7.13B | |
+3.84% | 108B | |
+11.20% | 104B | |
+1.28% | 22.33B | |
-13.09% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.06% | 17.64B | |
+3.68% | 14.05B | |
+36.73% | 12.51B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Insider Sold Shares Worth $1,980,900, According to a Recent SEC Filing